Menu Close

Trending

CSL Vifor plans UK launch after NICE backs rare disease drug Tavneos
Astellas files menopause drug fezolinetant in US, setting up Feb verdict
Frontiers Steering Committee spotlight: Megan Coder
Endo files for bankruptcy as it agrees opioid settlement
bluebird unveils $2.8m price for gene therapy Zynteglo on FDA approval

Katie Lucero

How to increase haematologists’ and oncologists’ confidence with new treatments

Deep Dive/ Oncology/ Views & Analysis/ Views and analysis

How to increase haematologists’ and oncologists’ confidence with new treatments

, , , , , , 0 Comment

A new whitepaper from Medscape highlights the difficulties haematologists and oncologists face in keeping up with rapid developments

X
How to increase haematologists’ and oncologists’ confidence with new treatments
https://pharmaphorum.com/views-analysis-oncology/how-to-increase-haematologists-and-oncologists-confidence-with-new-treatments/
Staying on the cutting edge of oncology advances

Deep Dive/ R&D/ Views & Analysis/ Views and analysis

Staying on the cutting edge of oncology advances

, , , , , 0 Comment

Rapidly-changing treatment landscapes in diseases like lung cancer pose challenges for medical education providers, who need to be

X
Staying on the cutting edge of oncology advances
https://pharmaphorum.com/r-d/views-analysis-r-d/cutting-edge-oncology-advances-medscape-medical-education/

Login

CONTINUE TO SITE >
X
Close in 10 seconds